107 related articles for article (PubMed ID: 8282251)
1. Two year maintenance treatment of duodenal ulcer disease with ranitidine 150 mg: a prospective multicentre randomised study. GEMUD (Groupe d'Etude de la Maladie Ulcéreuse Duodénale).
Ruszniewski P; Slama A; Pappo M; Mignon M
Gut; 1993 Dec; 34(12):1662-5. PubMed ID: 8282251
[TBL] [Abstract][Full Text] [Related]
2. [Intermittent treatment or preventive treatment of recurrence in duodenal ulcer disease? A controlled, double-blind study with 150 mg ranitidine daily for one year].
Mignon M; Ruszniewski P; Pappo M; Alberola B; Georges D
Gastroenterol Clin Biol; 1990; 14(10):732-8. PubMed ID: 2262119
[TBL] [Abstract][Full Text] [Related]
3. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer.
Jensen DM; Cheng S; Kovacs TO; Randall G; Jensen ME; Reedy T; Frankl H; Machicado G; Smith J; Silpa M
N Engl J Med; 1994 Feb; 330(6):382-6. PubMed ID: 8284002
[TBL] [Abstract][Full Text] [Related]
4. Maintenance ranitidine treatment after haemorrhage from a duodenal ulcer. A 3-year study.
Murray WR; Cooper G; Laferla G; Rogers P; Archibald M
Scand J Gastroenterol; 1988 Mar; 23(2):183-7. PubMed ID: 3283916
[TBL] [Abstract][Full Text] [Related]
5. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer.
Van Deventer GM; Elashoff JD; Reedy TJ; Schneidman D; Walsh JH
N Engl J Med; 1989 Apr; 320(17):1113-9. PubMed ID: 2651924
[TBL] [Abstract][Full Text] [Related]
6. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study.
Di Mario F; Battaglia G; Saggioro A; Chiozzini P; D'Angelo A; Marin R; Morelli A; Vezzadini P; Buscarini L; Cavassini G
Ital J Gastroenterol; 1991 Jun; 23(5):253-6. PubMed ID: 1742515
[TBL] [Abstract][Full Text] [Related]
7. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease.
Penston JG; Wormsley KG
Aliment Pharmacol Ther; 1992 Oct; 6(5):629-45. PubMed ID: 1420753
[TBL] [Abstract][Full Text] [Related]
8. [Controlled study with ranitidine for the prevention of recurrent duodenal ulcer].
Ocaña Andrade E; Porras Katz JC; Beltrán Escobar G; Jáuregui Garduño JL
Rev Gastroenterol Mex; 1997; 62(2):94-7. PubMed ID: 9471669
[TBL] [Abstract][Full Text] [Related]
9. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
10. Prevention of duodenal ulcer relapse with ranitidine.
Mekel RC; den Boer DJ
S Afr Med J; 1985 Sep; 68(6):385-6. PubMed ID: 3898417
[TBL] [Abstract][Full Text] [Related]
11. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
12. Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Breiter JR; Riff D; Humphries TJ
Am J Gastroenterol; 2000 Apr; 95(4):936-42. PubMed ID: 10763941
[TBL] [Abstract][Full Text] [Related]
13. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.
Ehsanullah RS; Page MC; Tildesley G; Wood JR
BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593
[TBL] [Abstract][Full Text] [Related]
14. Combined ranitidine and pirenzepine in the treatment of duodenal ulcer: a multicentre double-blind study using endoscopy.
Bianchi Porro G; Lazzaroni M; Mazzacca G; Piai G; Dal Monte PR; Colombo E; Ferrara A; Prada A; Battocchia A; Venturelli R
J Int Med Res; 1990; 18(5):341-50. PubMed ID: 2257957
[TBL] [Abstract][Full Text] [Related]
15. Seasonal behaviour of healed duodenal ulcer.
Gupta AK; Pal LS
J Indian Med Assoc; 1998 Apr; 96(4):106-8. PubMed ID: 9844330
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine in the treatment of peptic ulcer.
Makalinao AU; Zaño FM
Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
Cardi M; Muttillo IA; Amadori L; Barillari P; Sammartino P; Arnone F; Signorelli C; Bolognese A
Ann Chir; 1997; 51(2):136-9. PubMed ID: 9297869
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine and antacids in the prevention of duodenal ulcer relapse in Greece.
Kalantzis N; Theodoropoulos G; Katsaros D; Tzivras M; Fertakis A; Archimandritis A
Hepatogastroenterology; 1992 Jun; 39(3):277-9. PubMed ID: 1505904
[TBL] [Abstract][Full Text] [Related]
19. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
[TBL] [Abstract][Full Text] [Related]
20. [The recurrence of duodenal ulcer in patients undergoing treatment with ranitidine and placebo. A multicenter study].
Villalobos JJ; Nava AA; Elizondo J; Gallo S; Guerrero C; Vargas F; Barrera A; Centeno F; Marín E; Peña F
Rev Gastroenterol Mex; 1991; 56(2):65-9. PubMed ID: 1947617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
